Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian K. Rundall is active.

Publication


Featured researches published by Brian K. Rundall.


Journal of Biological Chemistry | 2006

Suberoylanilide Hydroxamic Acid Induces Akt-mediated Phosphorylation of p300, Which Promotes Acetylation and Transcriptional Activation of RelA/p65

Yuan Liu; Chadrick E. Denlinger; Brian K. Rundall; Philip W. Smith; David R. Jones

We have previously demonstrated that the transcription factor NF-κB is activated by histone deacetylase inhibitors in a PI3K/Akt-dependent manner. The molecular mechanisms governing this process have not been well described. By virtue of their inhibitory action, it is unclear whether the addition of histone deacetylase inhibitors simply preserves the acetylation status of RelA/p65 or whether they actively stimulate signaling cascades that result in increased acetylation and transcription of NF-κB. Here we provide evidence that suberoylanilide hydroxamic acid stimulates NF-κB transcription through a signaling cascade that involves activation of both the serine/threonine kinase Akt and the p300 acetyltransferase. Using newly developed phosphospecific antibodies to p300 (pSer1834), and site-directed mutant proteins, we find that suberoylanilide hydroxamic acid stimulates Akt activity, which is required to phosphorylate p300 at Ser1834. Akt-mediated phosphorylation of p300 dramatically increases its acetyltransferase activity as measured by an increased acetylation of RelA/p65 at Lys310, a modification that is required for full NF-κB transcription. Importantly, coordinate activation of Akt/p300 pathway by suberoylanilide hydroxamic acid occurs at the chromatin level, resulting in recruitment of activated Akt (pSer473), p300 (pSer1834), acetylated RelA/p65 (Lys310), and RNA polymerase II to the NF-κB-dependent cIAP-2 and Bfl-1/A1 promoters. These studies provide evidence that histone deacetylase inhibitors, such as suberoylanilide hydroxamic acid, not only inhibit deacetylase activity but also stimulate active NF-κB transcription and cell survival through signaling pathways involving Akt and increased p300 acetyltransferase activity.


Journal of Gastrointestinal Surgery | 2005

Laparoscopic gastric bypass complicated by gastric pouch necrosis: considerations in gastroesophageal reconstruction.

Brian K. Rundall; Chadrick E. Denlinger; Gene P. Parrino; Eugene F. Foley; David R. Jones

Gastric pouch necrosis and intraabdominal sepsis is an uncommon complication following laparoscopic gastric bypass. The intraoperative management of this complication centers on resection of the necrotic pouch, esophageal diversion, drainage, and enteral access for nutrition. Reestablishing gastrointestinal continuity at a later surgery following this complication can be challenging. We present a case in which the colon was found to be unacceptable for use in reconstruction; the remaining stomach was used as the conduit for a transhiatal reconstruction of gastrointestinal continuity instead.


The Annals of Thoracic Surgery | 2004

Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.

Chadrick E. Denlinger; Brian K. Rundall; Michael D. Keller; David R. Jones


The Journal of Thoracic and Cardiovascular Surgery | 2004

Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species

Chadrick E. Denlinger; Brian K. Rundall; David R. Jones


Surgery | 2004

Combined histone deacetylase and NF-κB inhibition sensitizes non-small cell lung cancer to cell death

Brian K. Rundall; Chadrick E. Denlinger; David R. Jones


Seminars in Thoracic and Cardiovascular Surgery | 2004

Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-κB

Chadrick E. Denlinger; Brian K. Rundall; David R. Jones


The Annals of Thoracic Surgery | 2006

Stage IB Nonsmall Cell Lung Cancers: Are They All the Same?

David R. Jones; Thomas M. Daniel; Chadrick E. Denlinger; Brian K. Rundall; Mark E. Smolkin; Mark R. Wick


The Journal of Thoracic and Cardiovascular Surgery | 2005

Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non–small cell lung cancer in vitro and in vivo

Chadrick E. Denlinger; Brian K. Rundall; David R. Jones


Surgery | 2005

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer

Brian K. Rundall; Chadrick E. Denlinger; David R. Jones


Journal of The American College of Surgeons | 2004

Efficacy of histone deacetylase inhibitors in NSCLC is attenuated by NF-kB acetylation

Brian K. Rundall; Chadrick E. Denlinger; David R. Jones

Collaboration


Dive into the Brian K. Rundall's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David R. Jones

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuan Liu

University of Virginia

View shared research outputs
Researchain Logo
Decentralizing Knowledge